Opportunity Information: Apply for PA 07 414
Apply for PA 07 414
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Genetic Epidemiology of Substance Use Disorders (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 5, 2008 and posted on Jul 24, 2007.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: City or township governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses County governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education State governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments).
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Genetic Epidemiology of Substance Use Disorders (R03) opportunity (Funding Opportunity Number PA-07-414) is an NIH discretionary grant program designed to fund small research projects that use genetic epidemiology to deepen what is known about substance use disorders and alcohol use disorders (SUDs/AUD), including drug and alcohol abuse and dependence. The core idea is to encourage focused, limited-scope studies that apply tools from genetic epidemiology to clarify how genetic risk and environmental exposures shape the onset, progression, and persistence of problematic substance use, and to use that knowledge to improve how the field defines, studies, and ultimately responds to these disorders.
A major emphasis of the announcement is on advancing understanding of developmental trajectories. Projects can examine how risk unfolds across time, such as from early experimentation through escalation, dependence, remission, and relapse, and how those pathways may differ across individuals and groups. Another key theme is disentangling genetic and environmental contributions to SUD/AUD. That includes studying gene-environment interplay (how environments may amplify or buffer inherited risk), separating shared family influences from individual-specific experiences, and clarifying which factors contribute to initiation versus chronicity. The FOA also explicitly encourages work that broadens and refines phenotypic definitions, meaning applicants can propose improved ways to measure and classify substance use problems beyond simple diagnostic categories. This can include dimensional symptom measures, intermediate traits, comorbidity patterns, age-of-onset subtypes, or other phenotype refinements that make genetic and epidemiologic analyses more informative.
The announcement also highlights translation as an intended payoff. While the projects are not required to be clinical trials or treatment studies, the expectation is that etiologic findings can guide practical next steps, such as identifying targets for prevention, tailoring interventions to risk profiles, improving screening approaches, or informing gene-finding and molecular research. In other words, this R03 mechanism is positioned as a way to generate early-stage evidence, sharpen hypotheses, and solve methodological obstacles that currently limit progress in the genetic epidemiology of addiction.
Mechanistically, this FOA uses the NIH Small Research Grant (R03) mechanism, which is meant for smaller, more contained studies rather than large multi-site efforts. The FOA specifically notes the kinds of work that fit well under R03, including pilot and feasibility studies, secondary analysis of existing datasets, small self-contained research projects, and the development of research methodology or new research technology. That framing signals that applicants do not necessarily need to build a new cohort from scratch; strong proposals could leverage existing family, twin, adoption, clinical, or population datasets, or develop/validate analytic methods and measurement approaches that can be scaled later. The scientific scope is aligned with companion FOAs that support the same topic area under larger or different mechanisms: an R01 version (PA-07-413) and an R21 version (PA-07-415), which allows investigators to choose the mechanism that best matches the maturity, scale, and risk level of their project.
From an administrative standpoint, the sponsoring agency is the National Institutes of Health, and the program is tied to CFDA numbers 93.273 (Alcohol Research Programs) and 93.279 (Drug Abuse and Addiction Research Programs). The opportunity does not require cost sharing or matching. The posting date is July 24, 2007, with multiple receipt dates listed in the full announcement, and the archive date is October 8, 2010, meaning it was available through recurring cycles during that period. For applicants who need eligibility clarity, the FOA indicates broad eligibility across many organization types, including state, county, city/township, and special district governments; public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (including small businesses); independent school districts; public housing authorities/Indian housing authorities; and Native American tribal governments and organizations. It also states that foreign institutions are eligible, eligible federal agencies may apply, and faith-based or community-based organizations can apply, which reflects NIH’s generally broad applicant eligibility for research grants.
In practical terms, the best-fitting applications are likely those that can accomplish something meaningful with limited resources and time: demonstrating feasibility, producing preliminary evidence that justifies a larger follow-on study, testing or improving phenotype definitions, applying genetic epidemiologic models to clarify causality and confounding, or addressing a methodological bottleneck that currently makes SUD/AUD genetic epidemiology harder than it needs to be. The full announcement is linked through the NIH grants guide (http://grants.nih.gov/grants/guide/pa-files/PA-07-414.html), and NIH’s Office of Extramural Research provides technical contact support for access or linking issues via FBOWebmaster@od.nih.gov.
FAQs: Genetic Epidemiology of Substance Use Disorders (R03) - NIH (PA-07-414)
What is the Genetic Epidemiology of Substance Use Disorders (R03) opportunity?
It is an NIH discretionary grant opportunity (Funding Opportunity Number PA-07-414) that funds small research projects using genetic epidemiology to increase understanding of substance use disorders and alcohol use disorders (SUDs/AUD), including drug and alcohol abuse and dependence.
What is the main purpose of this FOA?
The purpose is to encourage focused, limited-scope studies that apply genetic epidemiology tools to clarify how genetic risk and environmental exposures shape the onset, progression, and persistence of problematic substance use, and to use that knowledge to improve how the field defines, studies, and ultimately responds to these disorders.
What research topics are emphasized?
The announcement emphasizes (1) developmental trajectories of substance use and disorder (how risk unfolds over time), (2) disentangling genetic and environmental contributions (including gene-environment interplay and separating shared family influences from individual-specific experiences), and (3) broadening and refining phenotypic definitions for SUD/AUD beyond simple diagnostic categories.
What does the FOA mean by "developmental trajectories"?
It refers to studying how risk and outcomes change across time, such as pathways from early experimentation through escalation, dependence, remission, and relapse, and how these pathways may differ across individuals and groups.
What does "disentangling genetic and environmental contributions" include?
It includes studying gene-environment interplay (how environments may amplify or buffer inherited risk), separating shared family influences from individual-specific experiences, and clarifying factors that contribute to initiation versus chronicity (persistence) of SUD/AUD.
What kinds of phenotypes or measurements does the FOA encourage?
The FOA explicitly encourages improved ways to measure and classify substance use problems, such as dimensional symptom measures, intermediate traits, comorbidity patterns, age-of-onset subtypes, or other phenotype refinements that make genetic and epidemiologic analyses more informative.
Is translation to practice expected?
Yes. While projects are not required to be clinical trials or treatment studies, the intended payoff is that etiologic findings can guide practical next steps such as identifying targets for prevention, tailoring interventions to risk profiles, improving screening approaches, or informing gene-finding and molecular research.
Are clinical trials or treatment studies required?
No. The opportunity notes translation as a goal, but it does not require clinical trials or treatment-focused studies.
What grant mechanism is used?
This FOA uses the NIH Small Research Grant (R03) mechanism, which is intended for smaller, more contained research studies rather than large multi-site efforts.
What types of projects fit well under the R03 mechanism in this FOA?
The FOA highlights pilot and feasibility studies, secondary analyses of existing datasets, small self-contained research projects, and the development of research methodology or new research technology.
Do applicants need to build a new cohort to apply?
No. The FOA indicates that strong proposals can leverage existing family, twin, adoption, clinical, or population datasets, or focus on developing or validating analytic methods and measurement approaches that can be scaled later.
How does this R03 FOA relate to other NIH opportunities on the same topic?
The scientific scope is aligned with companion FOAs supporting the same topic area under other mechanisms: an R01 version (PA-07-413) and an R21 version (PA-07-415). This allows investigators to select a mechanism that matches the maturity, scale, and risk level of their project.
Who is the sponsoring agency?
The sponsoring agency is the National Institutes of Health (NIH).
What CFDA numbers are associated with this opportunity?
The program is tied to CFDA 93.273 (Alcohol Research Programs) and CFDA 93.279 (Drug Abuse and Addiction Research Programs).
Is cost sharing or matching required?
No. The opportunity states that cost sharing or matching is not required.
When was this FOA posted, and what is the archive date?
The posting date is July 24, 2007. The archive date is October 8, 2010, indicating it was available through recurring cycles during that period (with multiple receipt dates listed in the full announcement).
What organizations are eligible to apply?
The FOA indicates broad eligibility across many organization types, including state, county, city/township, and special district governments; public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (including small businesses); independent school districts; public housing authorities/Indian housing authorities; and Native American tribal governments and organizations.
Are foreign institutions eligible to apply?
Yes. The FOA states that foreign institutions are eligible.
Can federal agencies apply?
Yes. The FOA states that eligible federal agencies may apply.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly states that faith-based or community-based organizations can apply.
What kinds of datasets or study designs are mentioned as relevant?
The FOA notes that projects may leverage existing family, twin, adoption, clinical, or population datasets, consistent with genetic epidemiology approaches.
What is this FOA trying to produce in practical terms?
It is positioned to generate early-stage evidence, sharpen hypotheses, and solve methodological obstacles that limit progress in the genetic epidemiology of addiction, with the expectation that results can support follow-on work (for example, larger studies or more detailed molecular investigations).
Where can applicants find the full announcement?
The full announcement is available in the NIH Grants Guide at http://grants.nih.gov/grants/guide/pa-files/PA-07-414.html.
Who can be contacted for technical issues accessing the FOA link?
NIH Office of Extramural Research provides technical contact support for access or linking issues via FBOWebmaster@od.nih.gov.
Browse more opportunities from the same category: Education Health
Next opportunity: Genetic Epidemiology of Substance Use Disorders(R21)
Previous opportunity: Genetic Epidemiology of Substance Use Disorders(R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 414
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 414) also looked into and applied for these:
| Funding Opportunity |
|---|
| Genetic Epidemiology of Substance Use Disorders(R21) Apply for PA 07 415 Funding Number: PA 07 415 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Promotion Among Racial and Ethnic Minority Males (R21) Apply for PA 07 421 Funding Number: PA 07 421 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Promotion Among Racial and Ethnic Minority Males (R01) Apply for PA 07 422 Funding Number: PA 07 422 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 07 454 Funding Number: PA 07 454 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 07 455 Funding Number: PA 07 455 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Continued Development and Maintenance of Software (R01) Apply for PAR 08 010 Funding Number: PAR 08 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Angiogenesis in the Nervous System in Health and Disease (R01) Apply for PA 08 015 Funding Number: PA 08 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Angiogenesis in the Nervous System in Health and Disease (R21) Apply for PA 08 016 Funding Number: PA 08 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Quick Trials for Novel Cancer Therapies and Prevention Exploratory Grants (R21) Apply for PAR 08 025 Funding Number: PAR 08 025 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Research on Co Morbid Mental and Other Physical Disorders (R01) Apply for PA 08 029 Funding Number: PA 08 029 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exfoliated Cells, Bioactive Food Components, and Cancer (R01) Apply for PA 08 030 Funding Number: PA 08 030 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exfoliated Cells, Bioactive Food Components, and Cancer (R21) Apply for PA 08 031 Funding Number: PA 08 031 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Molecular Approaches to Diet and Pancreatic Cancer Prevention (R01) Apply for PA 08 032 Funding Number: PA 08 032 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Thyroid in Aging (R01) Apply for PA 08 037 Funding Number: PA 08 037 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Thyroid in Aging (R21) Apply for PA 08 038 Funding Number: PA 08 038 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Thyroid in Aging (R03) Apply for PA 08 039 Funding Number: PA 08 039 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Outcomes, Cost Effectiveness and the Decision Making Process to Use Complementary and Alternative Medicine (R01) Apply for PAR 08 045 Funding Number: PAR 08 045 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding and Preventing Brain Tumor Dispersal (R01) Apply for PAS 08 048 Funding Number: PAS 08 048 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Understanding and Preventing Brain Tumor Dispersal (R21) Apply for PAS 08 049 Funding Number: PAS 08 049 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Long Acting, Sustainable Therapies for Opiate Addiction (R01) Apply for PAS 08 061 Funding Number: PAS 08 061 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 414", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.